EpCAM Inhibition Sensitizes Chemoresistant Leukemia to Immune Surveillance

Cancer Research - United States
doi 10.1158/0008-5472.can-16-0842
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

Pharmacologic Inhibition of Fatty Acid Oxidation Sensitizes Human Leukemia Cells to Apoptosis Induction

Journal of Clinical Investigation
Medicine
2010English

Brca2Deficiency Sensitizes Cells to PARP Inhibition

Cancer Research
Cancer ResearchOncology
2006English

Targeting the High Mobility Group Box 3 Protein Sensitizes Chemoresistant Ovarian Cancer Cells to Cisplatin

Cancer Research
Cancer ResearchOncology
2019English

ATM Inhibition Sensitizes Tumors to High-Dose Irradiation

Cancer Research
Cancer ResearchOncology
2019English

Casein Kinase 2 Inhibition Sensitizes Medulloblastoma to Temozolomide

Oncogene
Cancer ResearchGeneticsMolecular Biology
2019English

Inhibition of SLC1A5 Sensitizes Colorectal Cancer to Cetuximab

International Journal of Cancer
Cancer ResearchOncology
2019English

Inhibition of SLC1A5 Sensitizes Colorectal Cancer to Cetuximab

International Journal of Cancer
Cancer ResearchOncology
2018English

Targeting HSF1 Sensitizes Cancer Cells to HSP90 Inhibition

Oncotarget
Oncology
2013English

PARP Inhibition Sensitizes Colorectal Cancer-Initiating Cells to Chemotherapy

Stem Cells
MedicineMolecular MedicineDevelopmental BiologyCell Biology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy